Cargando…

Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways

Regardless of the presence or absence of specific diagnostic mutations, many cancer patients fail to respond to EGFR-targeted therapeutics, and a personalized approach is needed to identify putative (non)responders. We found previously that human peripheral blood and EGF can modulate the activities...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamashev, Dmitri, Shaban, Nina, Lebedev, Timofey, Prassolov, Vladimir, Suntsova, Maria, Raevskiy, Mikhail, Gaifullin, Nurshat, Sekacheva, Marina, Garazha, Andrew, Poddubskaya, Elena, Sorokin, Maksim, Buzdin, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453612/ https://www.ncbi.nlm.nih.gov/pubmed/37626832 http://dx.doi.org/10.3390/cells12162022

Ejemplares similares

Human blood serum can donor-specifically antagonize effects of EGFR-targeted drugs on squamous carcinoma cell growth
por: Kamashev, Dmitry, et al.
Publicado: (2021)

Human Blood Serum Inhibits Ductal Carcinoma Cells BT474 Growth and Modulates Effect of HER2 Inhibition
por: Kamashev, Dmitrii, et al.
Publicado: (2022)

RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens
por: Sorokin, Maxim, et al.
Publicado: (2020)

Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas
por: Petrov, Ivan, et al.
Publicado: (2017)

Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing Profiles
por: Borisov, Nicolas, et al.
Publicado: (2021)

Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney Cancer
por: Gudkov, Alexander, et al.
Publicado: (2022)

Atlas of RNA sequencing profiles for normal human tissues
por: Suntsova, Maria, et al.
Publicado: (2019)

Algorithmically Reconstructed Molecular Pathways as the New Generation of Prognostic Molecular Biomarkers in Human Solid Cancers
por: Zolotovskaia, Marianna, et al.
Publicado: (2023)

RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancer
por: Sorokin, Maxim, et al.
Publicado: (2020)

Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite Instability
por: Sorokin, Maksim, et al.
Publicado: (2021)

Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
por: Vagapova, Elmira R., et al.
Publicado: (2021)

Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
por: Vagapova, Elmira R., et al.
Publicado: (2021)

Subtype of Neuroblastoma Cells with High KIT Expression Are Dependent on KIT and Its Knockdown Induces Compensatory Activation of Pro-Survival Signaling
por: Lebedev, Timofey, et al.
Publicado: (2022)

Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data
por: Sorokin, Maxim, et al.
Publicado: (2022)

Retroelement—Linked Transcription Factor Binding Patterns Point to Quickly Developing Molecular Pathways in Human Evolution
por: Nikitin, Daniil, et al.
Publicado: (2019)

Correction: Nikitin, D., et al. Retroelement—Linked Transcription Factor Binding Patterns Point to Quickly Developing Molecular Pathways in Human Evolution. Cells 2019, 8, 130
por: Nikitin, Daniil, et al.
Publicado: (2019)

DNA repair pathway activation features in follicular and papillary thyroid tumors, interrogated using 95 experimental RNA sequencing profiles
por: Vladimirova, Uliana, et al.
Publicado: (2021)

Large-scale assessment of pros and cons of autopsy-derived or tumor-matched tissues as the norms for gene expression analysis in cancers
por: Sorokin, Maksim, et al.
Publicado: (2023)

PB1760: PREDICTION OF DRUG SENSITIVITY AND GENETIC VULNERABILITY FOR ACUTE LEUKEMIA SUBTYPES USING GRAPH OF SIGNALING PATHWAY CORRELATIONS.
por: Lebedev, Timofey, et al.
Publicado: (2023)

Oncobox Bioinformatical Platform for Selecting Potentially Effective Combinations of Target Cancer Drugs Using High-Throughput Gene Expression Data
por: Sorokin, Maxim, et al.
Publicado: (2018)

RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual Biosamples
por: Sorokin, Maxim, et al.
Publicado: (2021)

Better Agreement of Human Transcriptomic and Proteomic Cancer Expression Data at the Molecular Pathway Activation Level
por: Raevskiy, Mikhail, et al.
Publicado: (2022)

MGL S3 Chimeric Enzyme Drives Apoptotic Death of EGFR-Dependent Cancer Cells through ERK Downregulation
por: Bondarev, Nikolay, et al.
Publicado: (2022)

Friends-Enemies: Endogenous Retroviruses Are Major Transcriptional Regulators of Human DNA
por: Buzdin, Anton A., et al.
Publicado: (2017)

Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes
por: Lebedev, Timofey, et al.
Publicado: (2021)

Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cells
por: Petrov, Ivan, et al.
Publicado: (2016)

Molecular pathway activation features linked with transition from normal skin to primary and metastatic melanomas in human
por: Shepelin, Denis, et al.
Publicado: (2015)

Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3′ Oncogenes from FFPE Bulk RNA Sequencing Data
por: Rabushko, Elizaveta, et al.
Publicado: (2022)

Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors
por: Spirin, Pavel, et al.
Publicado: (2017)

Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiation
por: Sorokin, Maxim, et al.
Publicado: (2017)

Reclassification of TCGA Diffuse Glioma Profiles Linked to Transcriptomic, Epigenetic, Genomic and Clinical Data, According to the 2021 WHO CNS Tumor Classification
por: Zakharova, Galina, et al.
Publicado: (2022)

Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma
por: Kim, Ella L., et al.
Publicado: (2020)

OncoboxPD: human 51 672 molecular pathways database with tools for activity calculating and visualization
por: Zolotovskaia, Marianna A., et al.
Publicado: (2022)

High-Throughput Mutation Data Now Complement Transcriptomic Profiling: Advances in Molecular Pathway Activation Analysis Approach in Cancer Biology
por: Buzdin, Anton, et al.
Publicado: (2019)

Profiling of Human Molecular Pathways Affected by Retrotransposons at the Level of Regulation by Transcription Factor Proteins
por: Nikitin, Daniil, et al.
Publicado: (2018)

A systematic experimental evaluation of microRNA markers of human bladder cancer
por: Zabolotneva, Anastasia A., et al.
Publicado: (2013)

Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma
por: Sorokin, Maxim, et al.
Publicado: (2021)

Transcriptomic Portraits and Molecular Pathway Activation Features of Adult Spinal Intramedullary Astrocytomas
por: Konovalov, Nikolay, et al.
Publicado: (2022)

New bioinformatic tool for quick identification of functionally relevant endogenous retroviral inserts in human genome
por: Garazha, Andrew, et al.
Publicado: (2015)

Distinct Traits of Structural and Regulatory Evolutional Conservation of Human Genes with Specific Focus on Major Cancer Molecular Pathways
por: Zakharova, Galina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jp171sg0dld2pe2ptgs9mvpvij